Canine Leptospirosis Market - Regional Analysis
North American Market Insights
North America industry is likely to hold largest revenue share of 35% by 2035. Regional market growth has been projected to be boosted by the presence of drug manufacturers. There are also important animals in the region that have been linked to the zoonotic disease of leptospirosis. This will result in more demand for leptospirosis diagnosis and treatment, stimulating the development of the region's market. Indeed, in the U.S. between 63 % and 66 % of households representing 86.9 million homes had a pet as of 2023 according to estimates provided by the American Pet Products Association 2024. Furthermore, according to Pet Keen's data of May 2023, Canada has the biggest proportion of cat and dog owners in all developed countries with cats accounting for over 38% of households and dogs around 35%.
Europe Market Insights
The canine leptospirosis market in the Europe region is set to hold a significant revenue share during the time period between 2026-2035. The growth of this market in the region can be attributed on the back of increasing investment in research and development activities. Furthermore, growing urbanization leads to increased contact between dogs and potential sources of leptospirosis bacteria, such as rats and contaminated water. Climate change and extreme events such as floods can also exacerbate the spread of the bacteria, creating new vulnerabilities for canine populations. This is set to accelerate the market growth in this region in the review period.
